author-photo

Peter Rieckmann

University of Würzburg

199

Papers

7110

Citations

Citation Trend

Filter By

Papers (141) Sort By

Journal Conference Others

[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].

2021 Nervenarzt
Show All
- Source
- Cite
- Save
Citations (2)
Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets in the CLARITY and CLARITY Extension Studies

2020 Multiple sclerosis and related disorders
Show All
- Source
- Cite
- Save
Citations (0)
Expert Opinion on the Use of Cladribine Tablets in Clinical Practice for the Treatment of Relapsing Multiple Sclerosis

2020 Multiple sclerosis and related disorders
Show All
- Source
- Cite
- Save
Citations (0)
Long-term disease stability assessed by the expanded disability status scale in patients treated with cladribine tablets in the clarity and clarity extension studies

2019 Journal of the Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (4)
Quantification of pupillary light reflex abnormalities in patients with neuromyelitis optica spectrum disorder and multiple sclerosis using automated infrared pupillometry

2019 Journal of the Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (0)
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.

2018 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (129)
Efficacy of Cladribine Tablets 3.5 mg/kg in High Disease Activity (HDA) Subgroups of Patients with Relapsing Multiple Sclerosis (RMS) in the CLARITY Study (P6.360)

2017 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
PO138 High disease activity in relapsing multiple sclerosis (rms)

2017 Journal of Neurology, Neurosurgery, and Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)
Defining High Disease Activity (HDA) in Patients with Relapsing Multiple Sclerosis (RMS) Receiving Placebo in the CLARITY Study (P6.351)

2017 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
PO137 Efficacy of cladribine tablets in high disease activity rms

2017 Journal of Neurology, Neurosurgery, and Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)